Rocket Pharmaceuticals, Inc. (RCKT) Dividend History

Rocket Pharmaceuticals, Inc. is a clinical-stage company focused on developing innovative gene therapies for rare pediatric diseases. Founded in 2015 and based in New York, the company leverages its platform to develop treatments aimed at addressing the underlying genetic causes of severe, often life-threatening conditions in children. Rocket Pharmaceuticals emphasizes a multidisciplinary approach, combining gene therapy, gene editing, and cellular therapy technologies to deliver potential cures for rare disorders.

350 Fifth Avenue, New York, NY, 10118
Phone: 646-440-9100
Website: https://www.rocketpharma.com

Dividend History

Rocket Pharmaceuticals, Inc. currently does not pay dividends

Company News

Dilated Cardiomyopathy Market Witnesses Robust Growth During the Study Period (2020–2034) Amid Advancements in Cardiovascular Therapies | DelveInsight

The dilated cardiomyopathy market is experiencing steady growth, driven by rising prevalence of heart failure, improved diagnostic techniques, and advancements in genetic testing. Increasing R&D investment in gene therapies and novel drug candidates is expanding treatment options.

GlobeNewswire Inc.

Featured Companies: AMGN BMY CPIX SLDB
Rocket Pharmaceuticals, Inc. Investors: Company Investigated by the Portnoy Law Firm

Rocket Pharmaceuticals, Inc. (RCKT) is under investigation by the Portnoy Law Firm for potential securities fraud after a participant in the company's Phase 2 pivotal trial for its gene therapy RP-A501 experienced a serious adverse event, leading to a clinical hold by the FDA and a significant drop in the company's stock price.

GlobeNewswire Inc.

Featured Companies: UNH URGN
Tempus AI, Inc. Investors: Company Investigated by the Portnoy Law Firm

The Portnoy Law Firm has initiated investigations into potential securities fraud at Tempus AI, UroGen Pharma, and Rocket Pharmaceuticals. The investigations are based on concerns raised in reports about the companies' accounting practices, executive affiliations, and key partnerships.

GlobeNewswire Inc.

Featured Companies: TEM URGN
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Rocket Pharmaceuticals, Inc. - RCKT

Rocket Pharmaceuticals, Inc. (RCKT) announced that a patient participating in a Phase 2 trial of its gene therapy for Danon disease experienced a serious adverse event, leading to a clinical hold by the FDA. The news caused a significant drop in the company's stock price.

GlobeNewswire Inc.
3 Stocks Insiders Are Buying Rapidly Amid Market Volatility

Amid market volatility, insiders have been rapidly buying shares in GameStop, Hallador Energy, and Rocket Pharmaceuticals, likely due to their positive outlook on the companies' prospects.

Investing.com

Featured Companies: GME HNRG

Dividend data last updated 06/07/2025 06:58:24 UTC